Refractory Immune Cytopenias
1 clinical trials · Condition
◉ Watch Refractory Immune Cytopenias
| Record | Firm | Date |
|---|---|---|
| Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation (NCT05873205) | Memorial Sloan Kettering Cancer Center | 2023-07-21 |
Track Refractory Immune Cytopenias automatically
Every clearance here is in the API, with alerts when new ones post.